Linike Medical Group Ltd
Linike Medical Group Ltd. engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd. in August 2021. Linike Medical Group Ltd. is based in Calgary, Canada.
Linike Medical Group Ltd (LNMG) - Total Assets
Latest total assets as of January 2025: $57.68 Million USD
Based on the latest financial reports, Linike Medical Group Ltd (LNMG) holds total assets worth $57.68 Million USD as of January 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Linike Medical Group Ltd - Total Assets Trend (2012–2024)
This chart illustrates how Linike Medical Group Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Linike Medical Group Ltd - Asset Composition Analysis
Current Asset Composition (October 2024)
Linike Medical Group Ltd's total assets of $57.68 Million consist of 48.3% current assets and 51.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.2% |
| Accounts Receivable | $9.44 Million | 17.0% |
| Inventory | $8.23 Million | 14.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Linike Medical Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Linike Medical Group Ltd's current assets represent 48.3% of total assets in 2024, a decrease from 94.5% in 2012.
- Cash Position: Cash and equivalents constituted 1.2% of total assets in 2024, down from 84.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 17.0% of total assets.
Linike Medical Group Ltd Competitors by Total Assets
Key competitors of Linike Medical Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Linike Medical Group Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Linike Medical Group Ltd generates 0.23x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Linike Medical Group Ltd is currently not profitable relative to its asset base.
Linike Medical Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.42 | 4.17 | 0.01 |
| Quick Ratio | 2.37 | 3.01 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $20.61 Million | $ 20.46 Million | $ -360.87 |
Linike Medical Group Ltd - Advanced Valuation Insights
This section examines the relationship between Linike Medical Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 1.7% |
| Total Assets | $55.65 Million |
| Market Capitalization | $108.24 USD |
Valuation Analysis
Below Book Valuation: The market values Linike Medical Group Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Linike Medical Group Ltd's assets grew by 1.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Linike Medical Group Ltd (2012–2024)
The table below shows the annual total assets of Linike Medical Group Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-10-31 | $55.65 Million | +1.73% |
| 2023-10-31 | $54.70 Million | +3871186.13% |
| 2022-10-31 | $1.41K | -62.28% |
| 2021-10-31 | $3.75K | +7.03% |
| 2020-10-31 | $3.50K | -37.33% |
| 2013-10-31 | $5.58K | -83.07% |
| 2012-10-31 | $32.99K | -- |